Reduced Plasmacytoid Dendritic Cell Output Is Associated With High Risk in Low-grade Myelodysplastic Syndrome
Hemasphere
.
2022 Feb 3;6(2):e685.
doi: 10.1097/HS9.0000000000000685.
eCollection 2022 Feb.
Authors
Alexander Chan
1
,
Ying Liu
1
2
,
Sean Devlin
3
,
Qi Gao
1
,
Jeeyeon Baik
1
,
Allison Sigler
1
,
Dory Londono
4
,
Maria Arcila
1
2
,
Ross Levine
5
,
Ahmet Dogan
1
,
Yanming Zhang
4
,
Mikhail Roshal
1
,
Wenbin Xiao
1
Affiliations
1
Department of Pathology and Laboratory Medicine, Hematopathology Service, Memorial Sloan Kettering Cancer Center, New York, USA.
2
Department of Pathology and Laboratory Medicine, Diagnostic Molecular Service, Memorial Sloan Kettering Cancer Center, New York, USA.
3
Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, USA.
4
Department of Pathology and Laboratory Medicine, Cytogenetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, USA.
5
Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, USA.
PMID:
35136856
PMCID:
PMC8815631
DOI:
10.1097/HS9.0000000000000685
No abstract available
Grants and funding
P30 CA008748/CA/NCI NIH HHS/United States